跳至主要内容
临床试验/DRKS00029090
DRKS00029090已完成4 期

Evaluation of a smartphone app for patients with panic disorder with or without comorbid agoraphobia

Mindable Health GmbH0 个研究点目标入组 107 人开始时间: 2022年6月10日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
107

研究概览

简要总结

Analyses confirmed significant group x time interaction effects for primary outcome (panic- and agoraphobia symptoms), and for one of the secondary outcomes (anxiety control). There were no effects for quality of life or impairment.

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • •One of the following diagnoses: F41.0, F40.00, F40.01; informed consent; Minimum age of 18 years

排除标准

  • •no smartphone; intake of benzodiazepines; initiation or changes in a psychopharmacotherapy during the last 2 months; komorbid psychotic disorder; komorbid substance use disorder; comorbid chronic cardiovascular or pneumological disorders; acute suicidality; ongoing psychotherapeutic treatment; not fluid in German language

研究者

发起方
Mindable Health GmbH

相似试验